Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 17:19:09 - browse：41335

The ability of cancer cells to move and spread depends on actin-rich core structures such as the podosomes (yellow) shown here in melanoma cells. Cell nuclei (blue), actin (red), and an actin regulator (green) are also shown. — Metastatic melanoma cells Julio C. Valencia,/NCI Center for Cancer Research

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from Iovance, is the first cell therapy approved for a solid tumor.

“It’s so exciting and gratifying,” said Allison Betof Warner, a cell therapy researcher and physician at Stanford University who has worked on Amtagvi. “This is a game-changing moment for our field. We’ve seen huge success of cellular therapy for hematologic malignancies, and we’ve yet to capitalize on that for solid tumors. This is hopefully the first of many to come.”

In a Phase 2 clinical trial, titled C-144-01, 153 patients who had already been on a median of three prior lines of therapy received lifileucel, and 31% of them responded to therapy. “These are in very late line patients. They’ve exhausted every standard care option,” Betof Warner said. “The most promising part of this therapy for me is that 42% of patients who responded were still responding for 18 months or longer. It’s truly incredible.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Apple is now the first public company to be valued at $3 trillion

hotspot

WSS

Supreme Court strikes down use of affirmative action

Fatty liver disease was alleviated by Lilly’s ‘triple

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

AstraZeneca lung cancer study comes in below expectations

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

entertainment

Wikipedia

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Heart attack and stroke risk calculators need revising

Prescription digital therapeutics are key to pharma’s future

Bright Health sells Medicare Advantage business to Molina

George Santos makes 1st court appearance after pleading not guilty to 13 counts

BioMarin wins approval for gene therapy to treat hemophilia A

What affirmative action's end means to a medical student

Hollywood unions extend contract negotiations for actors

The wait for US passports is creating travel purgatory and snarling summer plans

hotspot

Skip the lead apron during X

Jerome Adams on the need for new antivirals for Covid

Walensky prepares to leave CDC — and Congress — behind

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Beware reading your test results before your doctor does

Anesthesiologist group: stop taking Ozempic before surgery

explore

knowledge

hotspot

hotspot